{"title":"<i>Peptostreptococcus anaerobius</i> promotes cervical cancer angiogenesis by upregulating SCD to activate ERK pathway.","authors":"Yingxin Gong, Guannan Zhou, Yuanyuan Gu, Menglei Zhang, Ganrong Zhang, Zheng Gu, Junhao Chen, Hang Zhou, Jingxin Ding","doi":"10.62347/DYUN7645","DOIUrl":null,"url":null,"abstract":"<p><p>Accumulating evidence indicates that virginal microbiota dysbiosis is a distinct feature of cervical cancer. As cervical lesions progress towards malignancy, the dominance of <i>Lactobacillus</i> species within the vaginal microbiota is progressively replaced by anaerobic bacteria, with <i>Peptostreptococcus anaerobius</i> (<i>P. anaerobius</i>) being a noticeable one. Despite this well-documented microbial shift, the precise functional role of <i>P. anaerobius</i> in cervical cancer development and progression has remained unclear. Our study demonstrated that <i>P. anaerobius</i> promoted cervical cancer cells proliferation and enhanced tube formation of human umbilical vein endothelial cells (HUVECs). Furthermore, we identified a significant upregulation of stearoyl-CoA desaturase 1 (SCD) following the introduction of <i>P. anaerobius</i>, leading to subsequent activation of the extracellular signal-regulated kinase (ERK) signaling pathway. Moreover, supplement with <i>P. anaerobius</i> failed to reverse the ERK1/2 inhibitor-induced suppression of the tube-formation. <i>In vivo</i> validation revealed that <i>P. anaerobius</i> exerted its influence on angiogenesis by regulating SCD expression and ERK pathway acvivation. Collectively, these findings reveal an oncogenic role of <i>P. anaerobius</i> in cervical cancer, mediated by the SCD-ERK signaling axis to drive angiogenesis. This work provides novel mechanistic insights into the contribution of vaginal microbiota to gynecologic malignancies.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"15 7","pages":"3236-3244"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344179/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/DYUN7645","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Accumulating evidence indicates that virginal microbiota dysbiosis is a distinct feature of cervical cancer. As cervical lesions progress towards malignancy, the dominance of Lactobacillus species within the vaginal microbiota is progressively replaced by anaerobic bacteria, with Peptostreptococcus anaerobius (P. anaerobius) being a noticeable one. Despite this well-documented microbial shift, the precise functional role of P. anaerobius in cervical cancer development and progression has remained unclear. Our study demonstrated that P. anaerobius promoted cervical cancer cells proliferation and enhanced tube formation of human umbilical vein endothelial cells (HUVECs). Furthermore, we identified a significant upregulation of stearoyl-CoA desaturase 1 (SCD) following the introduction of P. anaerobius, leading to subsequent activation of the extracellular signal-regulated kinase (ERK) signaling pathway. Moreover, supplement with P. anaerobius failed to reverse the ERK1/2 inhibitor-induced suppression of the tube-formation. In vivo validation revealed that P. anaerobius exerted its influence on angiogenesis by regulating SCD expression and ERK pathway acvivation. Collectively, these findings reveal an oncogenic role of P. anaerobius in cervical cancer, mediated by the SCD-ERK signaling axis to drive angiogenesis. This work provides novel mechanistic insights into the contribution of vaginal microbiota to gynecologic malignancies.
期刊介绍:
The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.